Tobacco Researchers Challenge Misinformation on Nicotine E-cigarettes

Dec.13.2022
Tobacco Researchers Challenge Misinformation on Nicotine E-cigarettes
Tobacco researchers call for correction of misleading information from the CDC and Surgeon General regarding e-cigarettes.

A group of tobacco researchers has called on the US Centers for Disease Control and Prevention (CDC) and American surgeons to correct misinformation they shared about nicotine e-cigarettes in public health agencies.


The author has praised surgeon Vivek Murthy for his recent efforts to reduce the amount of misinformation surrounding health issues during the COVID pandemic but has cautioned both SG and CDC that these institutions are also actively promoting erroneous information regarding e-cigarettes. Specifically, the author references the CDC's incorrect information surrounding the 2019 lung injury outbreak known as "EVALI," and a 2016 report by the surgeon general regarding e-cigarette use among teenagers, which claimed that nicotine e-cigarettes were a gateway to teenage smoking.


The call was made in an editorial published today in the "Addiction" journal, co-authored by Michael Pesko, a health economist at Georgia State University, along with colleagues from Harvard Medical School, Pennsylvania State University, University of South Carolina School of Medicine, and University of Michigan. Tom Miller, Iowa's attorney general and former head of the Truth Initiative, is also a co-author.


The CDC will not abandon the misleading name "EVALI.


In the editorial, the author explains that the CDC used the name "EVALI" (e-cigarette or vaping product use-associated lung injury) to describe the 2019 lung injuries, and refused to change the name, which has resulted in ongoing misinformation in the media and scientific community about the cause of the situation.


During the outbreak of the pandemic, the CDC was the last public health agency to acknowledge that vitamin E acetate (which was being mixed with marijuana oil by black market sellers in order to save money) was the main cause, if not the sole cause, of injury. Additionally, the agency never fully ruled out nicotine e-cigarettes as having at least some responsibility for the outbreak. It is believed that Brian King, current director of the FDA's Center for Tobacco Products, created the name "EVALI." King was a staunch opponent of nicotine e-cigarettes at the time and is currently, and was at the time, an employee of the CDC's Office on Smoking and Health.


This product name has been linked to the deaths of 68 individuals and thousands of hospitalizations, due to the lack of warning from the country's primary public health agency regarding the risks of using unregulated THC pods. Many THC users continued to use the dangerous product because the Centers for Disease Control and Prevention intentionally avoided directly attributing their illness to vitamin E acetate, instead focusing on nicotine e-cigarettes as a potential cause. As a result, many nicotine e-cigarette users have reverted back to smoking traditional cigarettes.


The author argues that although the CDC's name includes "e-cigarettes," all evidence suggests that illegal tetrahydrocannabinol (THC) e-cigarettes contaminated with vitamin E acetate are the cause of the recent vaping illnesses, and no studies have found any chemicals in nicotine e-cigarettes as the cause. Vitamin E acetate is not soluble in nicotine vape oil and has never been detected in it.


Despite evidence, the Centers for Disease Control and Prevention continues to include "e-cigarettes" in the name EVALI. This naming has affected news reporting and fueled consumers' distorted beliefs about the risks of nicotine e-cigarettes.


In 2021, the same author formally requested that the CDC investigate changing the name "EVALI", removing "e-cigarette" from the name and adding "vitamin E acetate". The request was signed by an additional 68 experts, but was rejected by the Centers for Disease Control and Prevention.


Unprecedented Gateway to Smoking


When the Director of Health, in 2016, released a report titled "The Use of E-Cigarettes by Adolescents and Young Adults," it drew widespread attention from the country's newspapers and television news programs. However, as we noted at the time, few people were likely to bother reading the entire 298-page report, given that the SG's website offered a convenient shortcut.


The website of the Surgeon General still serves as an information resource regarding e-cigarettes and youth, and continues to mislead the public by implying that e-cigarettes are a known gateway for youth smoking. However, this is not accurate.


In an editorial, Pesko explained that "there is now a significant amount of evidence showing that the correlation between e-cigarettes and smoking is not a causal relationship, which has left the general public and healthcare professionals confused." Real-world data collected since the release of the SG report has emphasized the lack of causality. Even when youth e-cigarette use peaked in 2019, youth smoking rates were rapidly declining and continue to do so.


The author of the editorial describes how a "natural experiment" assesses how electronic cigarette restrictions implemented in certain places at specific times affect youth smoking, indicating an overall reduction in youth smoking due to the use of e-cigarettes. This natural experiment includes Pesko's own research on taxation, which showed that cigarettes and e-cigarette products are economic substitutes.


The 2016 Surgeon General's report did not take into account existing natural experiments that may have led its authors away from gateway claims. To this day, the SG website continues to ignore this evidence and claims that "there is no evidence to support the claim that e-cigarette use among young people may be protective against cigarette smoking.


A news release issued by co-author Cliff Douglas disputes misinformation from a website for surgeons indicating that the use of e-cigarettes leads young people to become smokers, which is not supported by evidence. "Despite a peak in teenage e-cigarette use in 2019, teenage smoking rates have recently reached an all-time low, below 2%," Douglas stated.


Will anyone pay attention?


Pesko and his colleagues wrote in an Addiction editorial that correlation does not imply causation. Public health officials, particularly the Surgeon General and the Centers for Disease Control and Prevention, must do a better job of explaining this difference to the public because public health advice should be based on reliable causal data and communicated clearly and appropriately to the general public.


The author pointed out that inaccurate information continues to be disseminated through news media, public health, and physician organizations, and is being used to advocate for "positive regulation of e-cigarettes, despite evidence suggesting this leads to increased use of combustible tobacco products." They wrote that correcting this misinformation is the "primary task of public health.


It should be a priority – an editorial itself should be a news story. However, it is doubtful whether it will catch the attention of health and science journalists. They did a great job last year by completely ignoring a more comprehensive paper that challenged misinformation about electronic cigarettes. The paper was written by 15 former chairs of the Nicotine and Tobacco Research Association.


Journalists and editors at major news outlets appear to be content with avoiding questioning of e-cigarette misinformation and falsehoods, when in fact they play a crucial role in disseminating such information. They often perpetuate dominant e-cigarette myths and provide oxygen for weak or selectively chosen supporting evidence to reinforce anti-e-cigarette orthodox views. The public's perception of e-cigarettes and other safer nicotine products cannot be altered until journalists begin to fully understand the harm caused by their passive, lazy, and dogmatic anti-e-cigarette advocacy.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Canada Vape Enforcement Action Puts VAPME Website, Trademark and China Supply-Chain Links in Focus
Canada Vape Enforcement Action Puts VAPME Website, Trademark and China Supply-Chain Links in Focus
Quebec police seized about 300,000 suspected illegal vape products and froze more than C$1.8 million in funds. Local media said vapme.ca, a website selling flavoured vape products, was shut down during the operation.
Regulations
Jun.18
France Bans Zyn and Other Nicotine Pouches, Violators Face Jail and Fines
France Bans Zyn and Other Nicotine Pouches, Violators Face Jail and Fines
France has officially banned nicotine pouches and other oral nicotine products, including Zyn. The new regulation classifies such products as “toxic substances” and imposes criminal penalties on their use, possession, purchase, and sale. Violators may face up to five years in prison and fines of up to €400,000 (approximately $436,600).
Regulations
May.25
Hawaii Restricts Vape Sales to FDA-Authorized Products, Disposable E-Cigarettes to Be Banned
Hawaii Restricts Vape Sales to FDA-Authorized Products, Disposable E-Cigarettes to Be Banned
Hawaii has enacted two new e-cigarette laws that significantly tighten market access requirements, requiring products to meet FDA authorization standards and banning disposable e-cigarette sales starting in 2027.
Jul.08
Vapesourcing Lists RELX Creator Pro 15K as “Coming Soon,” Shows U.S. Warehouse Shipping Options
Vapesourcing Lists RELX Creator Pro 15K as “Coming Soon,” Shows U.S. Warehouse Shipping Options
2Firsts found that U.S.-facing and cross-border vape retailer Vapesourcing has created a product page for the “RELX Creator Pro 15K Disposable Vape Kit 3%,” marked as “Coming Soon.” The page lists U.S. warehouse shipping options, but does not show that the product is currently available for purchase.
Market
Jun.08
Charlie’s Plans Q3 2026 Pilot of America’s First Age-Gated Flavored Disposable Vape
Charlie’s Plans Q3 2026 Pilot of America’s First Age-Gated Flavored Disposable Vape
U.S. vape company Charlie’s Holdings announced plans to pilot its age-gated flavored disposable vape products in hundreds of retail stores during the third quarter of 2026. The company said the products will utilize AI- and blockchain-powered age-verification technology designed to address FDA concerns over youth access and potentially create a new compliance pathway for flavored vape products.
Jun.15
Illegal Vape Retailers in UK Could Face 12-Month Shutdowns
Illegal Vape Retailers in UK Could Face 12-Month Shutdowns
The UK government plans to expand police and trading standards powers by extending closure orders for shops selling illegal vapes and cigarettes from a maximum of six months to 12 months, in a crackdown on organised crime on high streets.
Jun.12